People: Balchem Corp (BCPC.O)

Summary

Name	Age	Since	Current Position
Dino Rossi	57	2007	Chairman of the Board, President, Chief Executive Officer
Francis Fitzpatrick	51	2004	Chief Financial Officer, Treasurer, Assistant Secretary
Richard Bendure	42	2012	Chief Operating Officer
William Backus	45	2011	Chief Accounting Officer, Assistant Treasurer
David Ludwig	54	2000	Vice President, General Manager - Specialty Products
Matthew Houston	48	2005	General Counsel, Secretary
John Televantos	59	2010	Lead Independent Director
Paul Coombs	57	2010	Independent Director
David Fischer	50	2010	Independent Director
Edward McMillan	66	2003	Independent Director
Perry Premdas	60	2008	Independent Director
Elaine Wedral	68	2003	Independent Director
Karin McCaffery			IR Contact

» Insider Trading

Biographies

Name	Description
Dino Rossi	Mr. Dino A. Rossi is Chairman of the Board, President, Chief Executive Officer of Balchem Corporation. He has been a director of the Company since 1997 and Chairman of the Company’s Board of Directors since February 2007. Mr. Rossi has been President and Chief Executive Officer of the Company since October 1997, Chief Financial Officer of the Company from April 1996 to January 2004 and Treasurer of the Company from June 1996 to June 2003. He was Vice President, Finance and Administration of Norit Americas Inc., a wholly-owned subsidiary of Norit N.V., a Dutch chemicals company, from January 1994 to February 1996, and Vice President, Finance and Administration of Oakite Products Inc., a specialty chemicals company, from 1987 to 1993. In February 2010, Mr. Rossi was named a director of Scientific Learning Corporation (NASDAQ), where he is also the Chairman of the Compensation Committee and a member of the Audit Committee of its Board of Directors.
Francis Fitzpatrick	Mr. Francis J. Fitzpatrick, CPA, is Chief Financial Officer, Treasurer, Assistant Secretary of Balchem Corporation. He has been the Chief Financial Officer of the Company since January 2004 and Treasurer of the Company since June 2003, and was Controller of the Company from April 1997 to January 2004. He was Director of Financial Operations/Controller of Alliance Pharmaceutical Corp., a pharmaceuticals company, from September 1989 through March 1997.
Richard Bendure	Mr. Richard A. Bendure has been appointed as the Chief Operating Officer of Balchem Corporation, effective as of December 1, 2012. Prior to joining Balchem, Mr. Bendure was the Group Vice President, Americas, Water and Process Services for Nalco Company, an Ecolab, Inc. company (NYSE). Prior to this position, he served as Nalco's Group Vice President and Officer for its Global Strategic Business Units, where he led its overall business strategy and planning. This assignment was preceded by his role as President, Asia Pacific Business Operations, where Mr. Bendure directed all aspects of strategic planning, P&L management and operations for four business units across 13 countries in the Asia Pacific region.
William Backus	Mr. William A. Backus, CPA, serves as Chief Accounting Officer, Assistant Treasurer of Balchem Corporation since June 2011. Mr. He was Controller of the Company from January 2006 to June 2011. He was Controller of Stewart EFI, LLC., a precision metal component manufacturer, from 1999 through 2005.
David Ludwig	Mr. David F. Ludwig is Vice President and General Manager - Specialty Products of Balchem Corporation. He was Vice President and General Manager of Scott Specialty Gases, a manufacturer of high purity gas products and specialty gas blends, from September 1997 to June 1999. From 1986 to 1997 he held various international and domestic sales and marketing positions with Engelhard Corporation’s Pigments and Additives Division.
Matthew Houston	Mr. Matthew D. Houston is General Counsel, Secretary of Balchem Corporation. He was General Counsel and Secretary of Eximias Pharmaceutical Corporation, a privately held corporation, from 2001 to 2004. Mr. Houston also held several internal counsel positions at BASF Corporation, from 1994 to 2001. Mr. Houston received his Juris Doctorate from Saint Louis University.
John Televantos	Dr. John Y. Televantos, Ph.D., is Lead Independent Director of Balchem Corportion. Dr. Televantos has been a director since February 2005. Dr. Televantos is a Partner at Arsenal Capital Partners, Inc., a private equity investment firm, where he leads the Chemicals and Materials practice of the firm. Dr. Televantos was formerly with Hercules, Inc., a chemical manufacturing company, as President of the Aqualon Division and as Vice President of Hercules, Inc. from April 2002 through February 2005. Dr. Televantos holds B.S. and Ph.D. degrees in Chemical Engineering from the University of London, United Kingdom. In addition to Dr. Televantos’ experience in the chemical manufacturing industry and management of publicly traded chemical manufacturing entities, Dr. Televantos is also significantly involved in private equity markets and processes involving chemical manufacturing companies.
Paul Coombs	Mr. Paul D. Coombs serves as Independent Director of Balchem Corporation since September 16, 2010. From April 2005 until his retirement in June 2007, Mr. Coombs served as the Executive Vice President of Strategic Initiatives for Tetra Technologies, Inc. (NYSE), an oil and gas services company, and from May 2001 to April 2005, as its Executive Vice President and Chief Operating Officer. From January 1994 to May 2001, Mr. Coombs served as Tetra’s Executive Vice President – Oil & Gas. Mr. Coombs is a director of Tetra, where he is also a member of the Reserves Committee of the Board of Directors. Mr. Coombs has thirty years of experience in the oil and gas service and exploration industries, which, together with his entrepreneurial approach to management, provides the Board of Directors with essential counsel and insight into this area in which the Company seeks to expand.
David Fischer	Mr. David B. Fischer serves as Independent Director of Balchem Corporation since September 16, 2010. He is the President and Chief Executive Officer of Greif, Inc. (NYSE), a supplier of industrial packing systems, and has been in this position since November of 2011. From 2007 to 2011, Mr. Fischer was the President and Chief Operating Officer of Greif, and from 2004 to 2007, Mr. Fischer served as Greif’s Senior Vice President and Divisional President, Industrial Packaging & Services - Americas. Mr. Fischer holds a Bachelor of Science degree from Purdue University.
Edward McMillan	Mr. Edward L. McMillan is Independent Director of Balchem Corporation. Mr. McMillan owns and manages McMillan, LLC, a transaction-consulting firm that provides strategic consulting services and facilitates mergers and/or acquisitions predominantly to the food and agribusiness industry sectors. From 1988 to 1996, he was President and CEO of Purina Mills, Inc., where he was involved for approximately 25 years in various senior level positions in marketing, strategic planning, and business segment management. Since September 2005, he has been a director of NutraCea, a publicly traded OTC company and is currently the Chairman of the NutraCea Board. Mr. McMillan is also a member of the Board of Trustees for the University of Illinois in Champaign, Illinois.
Perry Premdas	Mr. Perry W. Premdas is Independent Director of Balchem Corporation. He is currently retired. From 1999 to 2004, Mr. Premdas was Chief Financial Officer of Celanese AG, a chemical and plastics business spun-off by Hoechst AG and listed on the Frankfurt stock exchange and the NYSE. He was Senior Executive Vice President and Chief Financial Officer of Centeon LLC from 1997 to 1998. Over his career, he has led treasury, finance, audit and investor relations functions of US and international companies and had general manager, executive and director roles in various wholly-owned and joint venture operations. Mr. Premdas holds a BA from Brown University and an MBA from the Harvard University Graduate School of Business. He is currently a member of the Board of Directors of Compass Minerals International, Inc. (NYSE). During the last five years, he also served as a director of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ) and Ferro Corporation (NYSE). Mr. Premdas has been Audit Committee Chairman.
Elaine Wedral	Dr. Elaine R. Wedral, Ph.D., is Independent Director of Balchem Corporation. Dr. Wedral is retired. Currently, she serves as the President of the International Life Sciences Institute in North America, which position she has held since January 2008. She was President of Nestlé R&D Center, Inc. and Head of the Nestlé Food Service Systems worldwide from 1999 to 2005. Prior to that, she held a variety of technical positions at Nestlé, including heading all of R&D for Nestle in North America. Dr. Wedral holds 34 patents in food processing, food nutrition and ingredient areas, and is on the editorial board of Food Processing Magazine. She received her Ph.D. from Cornell University in Food Biochemistry, an M.S. in Food Microbiology and a B.S. from Purdue University in Biochemistry. She is currently a director of Sensient Technologies Corporation (NYSE), where she is a member of its Finance Committee and Scientific Advisory Committee. Dr. Wedral continues to work with several key industry/university related groups in an advisory capacity.
Karin McCaffery

Basic Compensation

Name	Fiscal Year Total
Dino Rossi	1,784,920
Francis Fitzpatrick	814,935
Richard Bendure	--
William Backus	394,557
David Ludwig	644,828
Matthew Houston	337,791
John Televantos	--
Paul Coombs	--
David Fischer	--
Edward McMillan	--
Perry Premdas	--
Elaine Wedral	--
Karin McCaffery	--

As Of 30 Dec 2011

Options Compensation

Name	Options	Value
Dino Rossi	663,001	7,406,758
Francis Fitzpatrick	213,375	2,337,905
Richard Bendure	0	0
William Backus	23,250	678,078
David Ludwig	199,450	2,733,169
Matthew Houston	28,575	553,702
John Televantos	0	0
Paul Coombs	0	0
David Fischer	0	0
Edward McMillan	0	0
Perry Premdas	0	0
Elaine Wedral	0	0
Karin McCaffery	0	0

Insider Trading

Name	Shares Traded	Price
HOUSTON MATTHEW DAVID	9,000	$17.28
HOUSTON MATTHEW DAVID	16,875	$9.21
HOUSTON MATTHEW DAVID	15,000	$13.61
HOUSTON MATTHEW DAVID	41,229	$43.16
HOUSTON MATTHEW DAVID	6,750	$11.87
HOUSTON MATTHEW DAVID	6,900	$21.39
FITZPATRICK FRANCIS J	10,506	$5.85
FITZPATRICK FRANCIS J	10,506	$42.64
FITZPATRICK FRANCIS J	2,994	$42.33
FITZPATRICK FRANCIS J	2,994	$5.85
FITZPATRICK FRANCIS J	13,500	$42.92
FITZPATRICK FRANCIS J	15,823	$5.85
PUTNAM DANA E	27,000	$17.28
PUTNAM DANA E	27,000	$42.50
BENDURE RICHARD ALLEN	650	$41.28
ROSSI DINO A	14,925	$36.28
ROSSI DINO A	14,925	$5.85
HOUSTON MATTHEW DAVID	1,466	$0.00
ROSSI DINO A	5,757	$0.00
ROSSI DINO A	34,569	$5.85
LUDWIG DAVID F	3,081	$0.00
ROSSI DINO A	34,569	$37.88
FITZPATRICK FRANCIS J	2,456	$0.00
PUTNAM DANA E	1,617	$0.00
ROSSI DINO A	14,342	$36.28

» Full list on Insider Trading

People: Balchem Corp (BCPC.O)

Related Topics:

Summary

Biographies

Basic Compensation

Options Compensation

Related Topics: